genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Duchenne muscular dystrophy

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon
Artificial Intelligence

ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial
Drug Discovery

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial

FDA Approves Oral Nonsteroidal Treatment, Duvyzat, to Treat DMD
Drug Discovery

FDA Approves Oral Nonsteroidal Treatment, Duvyzat, to Treat DMD

Top 10 Biopharma Takeover Targets of 2024
A-Lists

Top 10 Biopharma Takeover Targets of 2024

ASHG President Brendan Lee Celebrates 75 Years of Research in Genetics and Genomics
Genome Editing

ASHG President Brendan Lee Celebrates 75 Years of Research in Genetics and Genomics

Remembering Terry Horgan
Genome Editing

Remembering Terry Horgan

Dual CRISPR RNA Method May Help Treat Duchenne Muscular Dystrophy
Genome Editing

Dual CRISPR RNA Method May Help Treat Duchenne Muscular Dystrophy

Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets
Drug Discovery

Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets

123...14Page 1 of 14

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up